Polymorphism in Xeroderma Pigmentosum Complementation Group C Codon 939 and Aflatoxin B1-Related Hepatocellular Carcinoma in the Guangxi Population

被引:56
作者
Long, Xi-Dai [1 ,2 ]
Ma, Yun [3 ]
Zhou, Yuan-Feng [2 ]
Ma, Ai-Min [2 ]
Fu, Guo-Hui [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Pathol, Shanghai 200025, Peoples R China
[2] Youjiang Med Coll Nationalities, Dept Pathol, Baise, Peoples R China
[3] Guangxi Med Univ, Dept Pathol, Nanning, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
NUCLEOTIDE-EXCISION-REPAIR; DNA-REPAIR; BREAST-CANCER; XPC POLYMORPHISMS; DAMAGE RECOGNITION; GENE POLYMORPHISMS; LUNG-CANCER; RISK; CHINA; P53;
D O I
10.1002/hep.23807
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Genetic polymorphisms in DNA repair genes may influence individual variations in DNA repair capacity, and this may be associated with the risk and outcome of hepatocellular carcinoma (HCC) related to aflatoxin B1 (AFB1) exposure. In this study, we focused on the polymorphism of xeroderma pigmentosum complementation group C (XPC) codon 939 (rs#2228001), which is involved in nucleotide excision repair. We conducted a case-control study including 1156 HCC cases and 1402 controls without any evidence of hepatic disease to evaluate the associations between this polymorphism and HCC risk and prognosis in the Guangxi population. AFB1 DNA adduct levels, XPC genotypes, and XPC protein levels were tested with a comparative enzyme-linked immunosorbent assay, Taq-Man polymerase chain reaction for XPC genotypes, and immunohistochemistry, respectively. Higher AFB1 exposure was observed among HCC patients versus the control group [odds ratio (OR) = 9.88 for AFB1 exposure years and OR = 6.58 for AFB1 exposure levels]. The XPC codon 939 Gln alleles significantly increased HCC risk [OR = 1.25 (95% confidence interval = 1.03-1.52) for heterozygotes of the XPC codon 939 Lys and Gln alleles (XPC-LG) and OR = 1.81 (95% confidence interval = 1.36-2.40) for homozygotes of the XPC codon 939 Gln alleles (XPC-GG)]. Significant interactive effects between genotypes and AFB1 exposure status were also observed in the joint-effects analysis. This polymorphism, moreover, was correlated with XPC expression levels in cancerous tissues (r = 0.369, P < 0.001) and with the overall survival of HCC patients (the median survival times were 30, 25, and 19 months for patients with homozygotes of the XPC codon 939 Lys alleles, XPC-LG, and XPC-GG, respectively), especially under high AFB1 exposure conditions. Like AFB1 exposure, the XPC codon 939 polymorphism was an independent prognostic factor influencing the survival of HCC. Additionally, this polymorphism multiplicatively interacted with the xeroderma pigmentosum complementation group D codon 751 polymorphism with respect to HCC risk (ORinteraction = 1.71). Conclusion: These results suggest that the XPC codon 939 polymorphism may be associated with the risk and outcome of AFB1-related HCC in the Guangxi population and may interact with AFB1 exposure in the process of HCC induction by AFB1. (HEPATOLOGY 2010;52:13011309)
引用
收藏
页码:1301 / 1309
页数:9
相关论文
共 36 条
  • [21] Identification of Potential Hub Genes Related to Aflatoxin B1, Liver Fibrosis and Hepatocellular Carcinoma via Integrated Bioinformatics Analysis
    Hamdy, Hayam
    Yang, Yi
    Cheng, Cheng
    Liu, Qizhan
    BIOLOGY-BASEL, 2023, 12 (02):
  • [22] Association analysis between the c.1804C&gt;A genetic polymorphism of XRCC1 gene and risk of hepatocellular carcinoma in Chinese population
    Liu, Yang
    Zhang, Aiqun
    Liu, Yu
    Dong, Jiahong
    MEDICAL ONCOLOGY, 2014, 31 (03)
  • [23] Genetic Polymorphism of MTHFR C677T Influences Susceptibility to HBV-Related Hepatocellular Carcinoma in a Chinese Population: a Case-Control Study
    Qiao, Kunyan
    Zhang, Shitian
    Trieu, Congdoanh
    Dai, Qinghai
    Huo, Zhixiao
    Du, Yanan
    Lu, Wei
    Hou, Wei
    CLINICAL LABORATORY, 2017, 63 (04) : 787 - 795
  • [24] The influence of caveolin-1 gene polymorphisms on hepatitis B virus-related hepatocellular carcinoma susceptibility in Chinese Han population: A case-control study
    Zhang, Jian
    Xue, Fangxi
    Chen, Shuhua
    Zhang, Dongqin
    Lu, Cuihong
    Tang, Gongen
    MEDICINE, 2017, 96 (42)
  • [25] A non-synonymous polymorphism in NBS1 is associated with progression from chronic hepatitis B virus infection to hepatocellular carcinoma in a Chinese population
    Zhen, Ya'nan
    Xiao, Ruixue
    Chen, Xing
    Yuan, Changjin
    Sun, Yanlai
    Li, Jie
    ONCOTARGETS AND THERAPY, 2018, 11 : 563 - 569
  • [26] Mannose-binding lectin 2 rs11003123 polymorphism is associated with the development of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis in the Chinese population
    Wang, Pu-Sen
    Kuai, Jing
    Li, Hao
    Wang, Chun-Guang
    Shi, Bao-Jie
    Zhong, Lin
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2016, 15 (03) : 282 - 288
  • [27] The KIF1B (rs17401966) Single Nucleotide Polymorphism is not Associated with the Development of HBV-related Hepatocellular Carcinoma in Thai Patients
    Sopipong, Watanyoo
    Tangkijvanich, Pisit
    Payungporn, Sunchai
    Posuwan, Nawarat
    Poovorawan, Yong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 2865 - 2869
  • [28] Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China
    Gao, Xia
    Liu, Wenxuan
    Zhang, Xiaolin
    Tang, Longmei
    Wang, Liqin
    Yan, Lina
    Yang, Haitao
    Li, Tao
    Yang, Lei
    Ma, Ning
    Liu, Dianwu
    TUMOR BIOLOGY, 2016, 37 (09) : 12103 - 12111
  • [29] Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma
    Su, Mingkuan
    Guo, Jianfeng
    Huang, Jiancheng
    CLINICAL AND MOLECULAR HEPATOLOGY, 2017, 23 (02) : 138 - 146
  • [30] DNA repair gene XRCC7 polymorphisms (rs#7003908 and rs#10109984) and hepatocellular carcinoma related to AFB1 exposure among Guangxi population, China
    Long, Xi-Dai
    Yao, Jin-Guang
    Huang, Yong-Zhi
    Huang, Xiao-Ying
    Ban, Fu-Zhi
    Yao, Li-Ming
    Fan, Lu-Dan
    HEPATOLOGY RESEARCH, 2011, 41 (11) : 1085 - 1093